Manjunath Jaya, Lei Donald, Ahmed Adnan, Ayasse Marissa, Chavda Rajeev, Gabriel Sylvie, Silverberg Jonathan Ian
Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC.
Department of Dermatology, Feinberg School of Medicine at Northwestern University, Chicago, IL.
Dermatitis. 2023 Jan-Feb;34(1):42-50. doi: 10.1089/DERM.0000000000000859.
Sleep disturbance (SD) is common in atopic dermatitis (AD). We examined the longitudinal course of SD and relationship with itch in AD patients. A prospective, dermatology practice-based study was performed (N = 1295) where patients were assessed at baseline and follow-up visits. At baseline, 16.9% of the patients had severe SD based on Patient-Reported Outcomes Information System (PROMIS) SD scores, 19.1% had difficulty falling asleep, 22.9% had difficulty staying asleep, and 34.2% had SD from AD. A total of 31.4% of the patients with difficulty staying asleep at baseline experienced persistent difficulties (for 3 follow-ups or more). Only 17.7% with baseline difficulty falling asleep had persistent disturbance. Despite significant fluctuation in sleep scores, SD generally improved over time. Of the patients facing baseline SD from AD, 31.5% experienced SD at the first visit, and only 12.3% experienced persistent SD at the second follow-up visit. Predictors of increased PROMIS sleep-related impairment scores over time included baseline PROMIS sleep-related impairment scores (0.74 [0.68-0.80]), having 3 to 6 nights of itch (2.22 [0.85-3.59]), and severe/very severe AD (4.40 [2.60-6.20]). A significant proportion of adult AD patients, particularly those with moderate-severe AD and frequent itch, had baseline SD. Although sleep scores generally improved over time, many patients experienced a fluctuating or persistent course.
睡眠障碍(SD)在特应性皮炎(AD)中很常见。我们研究了AD患者SD的纵向病程及其与瘙痒的关系。进行了一项基于皮肤科实践的前瞻性研究(N = 1295),在基线和随访时对患者进行评估。在基线时,根据患者报告结局信息系统(PROMIS)的SD评分,16.9%的患者有严重SD,19.1%的患者入睡困难,22.9%的患者难以维持睡眠,34.2%的患者因AD出现SD。基线时难以维持睡眠的患者中,共有31.4%经历了持续性困难(随访3次或更多次)。基线时入睡困难的患者中只有17.7%有持续性障碍。尽管睡眠评分有显著波动,但SD总体上随时间有所改善。在基线时因AD出现SD的患者中,31.5%在首次随访时仍有SD,在第二次随访时只有12.3%有持续性SD。随时间推移PROMIS睡眠相关损害评分增加的预测因素包括基线PROMIS睡眠相关损害评分(0.74 [0.68 - 0.80])、有3至6晚瘙痒(2.22 [0.85 - 3.59])以及重度/极重度AD(4.40 [2.60 - 6.20])。相当一部分成年AD患者,尤其是中重度AD和频繁瘙痒的患者,有基线SD。尽管睡眠评分总体上随时间有所改善,但许多患者经历了波动或持续的病程。